Echouffo-Tcheugui, Justin B.
Musani, Solomon K.
Bertoni, Alain G.
Correa, Adolfo
Fox, Ervin R.
Mentz, Robert J.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K23 HL153774., U01HL125511-01A1)
Article History
Received: 5 March 2022
Accepted: 28 March 2022
First Online: 1 June 2022
Declarations
:
: The study protocol was approved by the institutional review board of the University of Mississippi Medical Center, Jackson State University and Tugaloo College. All the participants provided informed consent.
: All the authors gave their consent for publication.
: Robert J Mentz receives research support from Amgen, AstraZeneca, Bayer, GlaxoSmithKline, Gilead, InnoLife, Luitpold/American Regent, Medtronic, Merck, Novartis and Sanofi; honoraria from Abbott, Amgen, AstraZeneca, Bayer, Boston Scientific, Janssen, Luitpold Pharmaceuticals, Medtronic, Merck, Novartis, Roche, Sanofi and Vifor; and has served on an advisory board for Amgen, AstraZeneca, Luitpold, Merck, Novartis and Boehringer Ingelheim. The other authors report no conflicts of interest.